Cargando…
Neutralizing monoclonal antibodies present new prospects to treat SARS-CoV-2 infections
The coronavirus disease 2019 (COVID-19) has caused global public health and economic crises. Thus, new therapeutic strategies and effective vaccines are urgently needed to cope with this severe pandemic. The development of a broadly neutralizing antibody against severe acute respiratory syndrome cor...
Autores principales: | Lai, Rongtao, Zhou, Tianhui, Xiang, Xiaogang, Lu, Jie, Xin, Haiguang, Xie, Qing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Higher Education Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8079842/ https://www.ncbi.nlm.nih.gov/pubmed/33909259 http://dx.doi.org/10.1007/s11684-021-0847-4 |
Ejemplares similares
-
Liver dysfunction and SARS-CoV-2 infection
por: Gracia-Ramos, Abraham Edgar, et al.
Publicado: (2021) -
Modelling the downhill of the Sars-Cov-2 in Italy and a universal forecast of the epidemic in the world
por: Martelloni, Gabriele, et al.
Publicado: (2020) -
Orphan patients with inflammatory bowel disease - when we treat beyond evidence
por: Privitera, Giuseppe, et al.
Publicado: (2021) -
Constructing high-accuracy theoretical Raman spectra of SARS-CoV-2 spike proteins based on a large fragment method
por: Ni, Shuang, et al.
Publicado: (2022) -
Endothelial dysfunction in COVID-19 calls for immediate attention: the emerging roles of the endothelium in inflammation caused by SARS-CoV-2
por: Hang, Weijian, et al.
Publicado: (2021)